Abstract: A system and method for sanitizing a target space include an ultraviolet (UV) lamp, an occupancy sensor, and a control unit operably connected to the occupancy sensor and the UV lamp. The UV lamp is configured to emit UV light into the target space. The occupancy sensor is configured to monitor the target space and generate sensor signals indicative of an occupancy of the target space by at least one person. The control unit is configured to receive the sensor signals generated by the occupancy sensor and to modulate an irradiance of the UV light emitted by the UV lamp over time based on the occupancy of the target space.

Abstract: A system and method for disinfecting one or more components include one or more ultraviolet (UV) lamps. The one or more UV lamps include one or more UV light emitters configured to emit UV light, and a mounting interface removably securable to a securing mount.

Abstract: Systems and methods are provided for disinfection. One embodiment is an apparatus that includes a disinfecting device. The disinfecting device includes a shell configured to rotate about an axis, ultraviolet emitters that are configured to emit UV light, and rotational couplings that couple the UV emitters to the shell, and provide for multi-axial rotation of the UV emitters relative to the shell.

Abstract: Systems and methods are provided for disinfecting. One embodiment includes a disinfecting device. The disinfecting device includes a housing having an attachment surface and an illumination surface that are opposed along an axis, and a plurality of adjustable ultraviolet (UV) emitters disposed at the housing that have fields of illumination that are adjustable along multiple axes via rotational couplings to illuminate an enclosed space that the illumination surface faces.

Abstract: The invention relates to a device for use with medical products which can be disinfected by means of a UV-C light treatment, which device is provided with: at least one sensor for registering a UV-C light dose of the UV-C light treatment; at least one activable reset unit which can perform a memory reset of a memory of the device; at least one indicator; at least one logic module which is operatively connected to the memory, the sensor, the reset unit and the indicator, wherein the logic module is configured to determine whether the product has been disinfected in a prescribed way on the basis of the UV-C dose registered by the sensor and to determine whether the reset unit has been activated, wherein, by means of the logic module, the memory can be placed in a first state, corresponding to a product disinfected in the prescribed way, and can be placed in a second state, corresponding to the memory reset by means of the activated reset unit, wherein the state of the memory is externally communicable by mea

Abstract: A sanitization device and telemedicine station (SDTS) may automatically detect and disinfect users as the users pass through the device. Sanitizing solution may be distributed throughout a disinfecting area within the SDTS such that people, pets, items, and/or other objects are disinfected. The SDTS may collect biometric data such as body temperature. Collected data may be analyzed to identify conditions and/or generate recommendations by matching collected data to various condition profiles. The SDTS may allow telemedicine sessions, where a user may communicate with a practitioner or virtual practitioner.

Abstract: A device for the generation of ozone, comprising: at least one ozone-producing cell equipped with an inlet and with an outlet and adapted to convert into ozone at least a part of the oxygen contained in an aeriform stream of environment air that passes through it from said inlet towards said outlet, at least one conveying duct configured to convey environment air towards the inlet of the ozone-producing cell, a filtering arrangement placed along said conveying duct to filter the environment air before it reaches the ozone-producing cell, wherein said filtering arrangement comprises a granular filter comprising at least silicate granules.

Abstract: Methods for generating a sterilant vapor in a sub-atmospheric environment for use in sanitization and sterilization. The vapor is generated from a mixture containing a sterilant and a molecular mobility enhancer (MME). More specifically, the use of the MME enhances the vaporization and mobility of the sterilant, particularly hydrogen peroxide and/or a peroxy acid, to provide enhanced or improved sterilization. Also provided are solid-form sterilant comprising a sterilant and an MME. Further provides are various packaged forms of sterilant, particularly containing hydrogen peroxide and/or a peroxy acid for use in sanitation and sterilization methods herein.

Abstract: The present invention is directed to methods and apparatus for pathogen decontamination of personal protective equipment (PPE), face filtering respiratory devices (FFR) and single use medical devices (SUD) by supercritical fluids, near critical fluids, and critical fluids with or without polar cosolvents. The invention includes a closed processing chamber for containing and processing the PPE, FFR, and SUD by a supercritical fluid, near critical fluid, and critical fluid with or without polar solvents at a specified temperature and pressure for a specified time sufficient to disrupt or inactivate pathogens and viruses on the PPE, FFR, and SUD without damaging the protective equipment so that they may be revitalized for continued use.

Abstract: An antimicrobial composition includes an organic extract, such as a witch hazel extract, and a colloid selected from metal, halogen, and combinations of these, such as a silver colloid. The witch hazel extract includes tannins in excess of about 10 mg/ml, such as hamamelitannin, and the colloid includes about 10,000 PPM of metal, such as silver. The antimicrobial composition may be applied to or instilled through an indwelling urinary catheter or other medical device.

Abstract: A system and method for disinfecting one or more components include an ultraviolet (UV) lamp including a plurality of modules coupled together. Each of the plurality of modules comprises one or more UV light emitters that are configured to emit UV light onto the one or more components. In at least one embodiment, a control unit is in communication with an IR sensor and the UV lamp. The control unit is configured to selectively activate and deactivate the one or more UV light emitters based on one or more IR signals received from the IR sensor. In at least one embodiment, at least a portion of the plurality of modules is covered with one or more electromagnetic interference (EMI) shields.

Abstract: A system and a method of managing requirements for foodstuffs with processing line changes output assessment reports and work orders for an efficient processing of products. The system includes at least one computing system which manages and processes information inputted by the user. A user can create product profiles which include attribute information. The attribute information can be entered or selected by the user. The computing system compares the product profiles amongst each other in order to identify compatible product profiles and incompatible product profiles. The computing system then generates at least one processing instruction for each product profile based on the compatible product profiles and the incompatible product profiles. The processing instruction for each product profile is outputted as an assessment report and a work order which can be used to instruct employees on how to clean and verify products in a production line.

Abstract: A system and method for disinfecting hard surfaces in an area such as a hospital room including a light source emitting UV light and a reflector mounted behind the light source for concentrating and directing the light toward a target. The light source and reflector rotate to direct the concentrated beam around a room, thereby making more efficient use of the energy being emitted.

Abstract: A microwave device for inactivation of viruses is disclosed. The microwave device comprising a housing and a field generator. The housing has a cavity configured to receive an object contaminated with viruses within the cavity and the field generator is configured to irradiate the cavity with microwave energy at a band of frequencies and a power level configured to inactivate the virus. The cavity is located within a near-field of a radiation pattern produced by the field generator at the band of frequencies and the microwave energy causes a dipole vibration on the virus that causes the virus to fracture.

Abstract: A sterilization challenge device for verifying the efficacy of a sterilization process includes a container, an insert member, a sterilization indicator, and a cap. The container includes an open end, a closed end, a chamber configured to contain the biological indicator and the insert member, and at least one hole arranged proximate the open end. The cap is configured to engage with the container to close the open end, and the at least one hole is configured to provide a flow path for the gaseous sterilant into the chamber.

Abstract: A method for decontaminating an environment includes measuring an ozone concentration value present inside the environment and repeatedly carrying out a sequence of steps comprising: increasing the quantity of ozone present in the environment until the measured ozone concentration value reaches a first value and lowering the quantity of ozone present in the environment until the measured ozone concentration value reaches a second value lower than the first value.

Abstract: A disposable capsule for aerial diffusion of an aromatherapy composition formed from a mixture of essential oil and water, by use of an aerial diffusion device. The capsule includes a shell, the shell having at least a first reservoir containing an essential oil, and a second reservoir containing water, the first reservoir and the second reservoir being hermetically separated from one another.

Abstract: An apparatus, system, and method are disclosed for dry fogging system. The system includes a first liquid tank including compressed air and a first liquid configured to disinfect and sterilize. The system further includes a second liquid tank including a second liquid. The system further includes a control panel configured to regulate dispensing of the first liquid and the second liquid. The first liquid tank, the second liquid tank, and the control panel are modular and configured to detach.

Abstract: An intelligent full-time sterilization lighting device is disclosed. It contains an external casing, a plurality of ultraviolet sterilization light source, an airflow driving module and control module. Based on the designs of the air channel portion, the air inlet portion and the air outlet portion external casing, it is allowed to hide the ultraviolet sterilization light source in the air channel portion. It can sterilize the airflow introduced by the airflow driving module without harming the surrounding people. Indoor lighting can be provided under the external casing. In addition, the shape of the external casing can be designed according to the size of the calcium silicate board of the existing light steel frame. It is easy to install on light steel frame.

Abstract: A multifunction UV disinfecting fixture includes a housing with a wall or ceiling mount, a blower, a UV source, and a shield mechanism. The shield mechanism provides a closed configuration that directs an air flow created by the blower past the UV source for air disinfection and that shields a surroundings of the disinfector from the UV source. The shield mechanism further provides an open configuration in which the UV light from the UV source is directed out of the disinfector to surfaces for surface disinfection in the surroundings. The disinfector may further employ a filter or an ionizer.

Abstract: An ultraviolet air germicidal lamp system includes a base frame including an air inlet and an air outlet, an ultraviolet germicidal module on the base frame, and a lamp module in the base frame. The ultraviolet germicidal module includes a fan, an inlet duct, an ultraviolet lamp module including a cavity and ultraviolet lamps in the cavity, and an outlet duct. The fan is connected to the air inlet. The intake of the cavity of the ultraviolet lamp module is connected to the fan by the inlet duct. The vent of the cavity of the ultraviolet lamp module is connected to the air outlet by the outlet duct. The body diameter of the cavity is larger than the diameters of the inlet duct and the outlet duct.

Abstract: A light sterilizing apparatus includes a light source mechanism and a flow carrier, wherein the light source mechanism is positioned outside the flow carrier, the light source mechanism emits sterilizing light with a wavelength of 200-280 nm, the light emitted by the light source mechanism passes through a light transmission part of the flow carrier and enters a channel part of the light source mechanism, and a channel in the channel part is a winding channel. Configuring the channel as a winding channel prolongs the duration of air flowing in the flow carrier, and thus renders a longer sterilization process, which guarantees the sterilization effect and effectively reduces the size of the light source mechanism and the flow carrier; as a result, the light sterilizing apparatus can be suitable for various scenarios and wide application.

Abstract: An air collection and cleaning system or apparatus including a computer monitor, wherein the computer monitor in addition to displaying images, information, and/or data, comprises an exhaled air collector, wherein the computer monitor's computer screen forms an exhaled air blocking surface which is part of the exhaled air collector and wherein the exhaled air collector collects exhaled air, and the computer screen's surface deflects exhaled air towards an exhaled air suction intake, an air purification unit, or both.

Abstract: This application relates to an air sterilizer and an air sterilization method using same. In one aspect, the air sterilizer includes a housing including a flow path through which air moves. The air sterilizer may also include a first sterilization module configured to emit an electromagnetic wave to the air to sterilize the air, and a second sterilization module configured to remove a microorganism in the air using an electrostatic force. The first sterilization module may adjust a wavelength of the electromagnetic wave so that an intensity of the electromagnetic wave is determined based on a type of the microorganism, by controlling a tube voltage of the electromagnetic wave.

Abstract: An air sanitiser unit includes a housing including a base with one or more mounting formations for mounting the base on a substantially vertical wall or support structure and a lid having an air inlet vent and an air outlet vent. The lid is releasably attached to the base to provide an enclosure. At least one ultraviolet lamp is enclosed within the housing to prevent exposure of the ultraviolet lamp from outside of the housing. One or more diffuser elements are enclosed in the housing adjacent to the ultraviolet lamp including one or more photocatalysts. A control device is enclosed in the housing with an alarm device. The control device is electrically connected to the ultraviolet lamp and the alarm device and is configured to control the alarm device according to the status of the ultraviolet lamp.

Abstract: A composition comprising an acrylic adhesive, a thermoplastic absorbent polymer, and a gelling agent, a wound dressing comprising said composition, methods of making said composition and wound dressing, and the uses of said composition and wound dressings for treatment of wounds and/or for securement of devices to the skin.

Abstract: The present invention is directed to hemostatic sealants having a compressed porous substrate, an electrophilic group containing component that is not gelatin or collagen, a nucleophilic group containing component, and a buffering agent. The present invention also relates to method for manufacture and use of such sealants to seal and/or achieve hemostasis.

Abstract: A method of making a cellulose-nanoclay hemostatic nanocomposite fiber, including the steps of preparing a homogenous cellulose solution including cellulose and a room temperature ionic liquid, preparing a nanoclay suspension including halloysite and distilled water, electrospinning the cellulose solution into a first bath including the nanoclay suspension, transferring solidified cellulose-halloysite fibers from the first bath to a second bath including ethanol and distilled water, removing the solidified cellulose-halloysite fibers from the second bath, and freeze-drying the solidified cellulose-halloysite fibers.

Abstract: In some aspects, the disclosure pertains to injectable particles that contain at least one pH-altering agent that is configured to be released from the injectable particles in vivo, upon embolization of an intratumoral artery of a tumor with the injectable particles. In certain instances, the pH altering agent may be a basic agent having a pH value of 7.5, a buffering agent having a pKa value of 7.6 or more, or both. Other aspects of the disclosure pertain to preloaded containers containing such injectable particles and methods of using such injectable particles.

Abstract: There is provided a bone cement composition comprising: a powder component comprising at least one acrylic polymer a liquid component comprising a monomer; an antibiotic; and an acid-functionalised polymer, wherein reaction of the powder component and the liquid component results in formation of a bone cement. In a preferred embodiment, the acid-functionalised polymer is selected from polyethylene glycol-polycarbonate (PEG-PAC), polycarbonate-poly(L-lactide) (PAC-PLLA), polycarbonate-poly(D-lactide) (PAC-PDLA), PAC-PLLA/PDLA, copolymers thereof or a combination thereof. There is also provided a bone cement formed from the bone cement composition.

Abstract: Additive-manufacturing systems for forming non-woven fibrous implants are disclosed. Additive-manufacturing systems may include a robotic subsystem having scanning and imaging equipment configured to scan a patient's anatomy, and an armature including at least one dispensing nozzle configured to selectively dispense at least one material. The system may further include a controller apparatus configured to send a control signal to control the scanning and imaging equipment to determine a target alignment of a patient's spine, and develop an additive-manufactured printing plan including an additive-manufactured material selection plan based on the target alignment of the patient's spine. The controller may execute the additive-manufactured printing plan to: dispense the at least one material to form a non-woven fibrous component.

Abstract: The present invention relates to a bone regeneration material comprising: a solid first phase of hydroxyapatite of natural origin which is macroporous, having pores of diameters greater than or equal to 50 ?m, this phase of hydroxyapatite is a crystalline solid phase of hydroxyapatite, whose crystals have a size comprised between 20 and 120 nm, and this solid phase of hydroxyapatite has a specific surface area comprised between 8 and 20 m2/g, the method of production and a method of bone repair based on this bone regeneration material.

Abstract: A composite comprising: a barrier, said barrier being configured to selectively pass water, and said barrier being degradable in the presence of water; a matrix material for disposition within said barrier, wherein said matrix material has a flowable state and a set state, and wherein said matrix material is degradable in the presence of water; and at least one reinforcing element for disposition within said barrier and integration with said matrix material, wherein said at least one reinforcing element is degradable in the presence of water, and further wherein, upon the degradation of said at least one reinforcing element in the presence of water, provides an agent for modulating the degradation rate of said matrix material in the presence of water.

Abstract: The present invention concerns a novel use of therapeutic hydrogels in nonsurgical techniques to promote healing and regeneration of tissues whose structure and functions have been diminished due to chronic inflammatory disorders. More particularly, the invention provides therapeutic and regenerative hydrogel compositions and their nonsurgical delivery to periodontal treatment sites to treat periodontal and peri-implant diseases. Furthermore, the invention concerns a novel technique which involves the injection of said sterile therapeutic biomimetic hyaluronic acid hydrogel to which are tethered at least one host modulating agent, such as tetrahydrocurcuminoids, THC, and at least one additional tissue regenerative agent into the gingival connective tissue proper.

Abstract: The disclosure provides implants containing a plurality of particles containing at least one population of viable cells adherent to and resident in soft tissue matrix or at least one viable population of cells caused to be in contact with the soft tissue matrix; methods of fabricating the implants; and use of the implants in tissue repair.

Abstract: The present application relates to a tissue engineering bone scaffold and a preparation method thereof, and the method includes the following steps: a cleaning step, subjecting tissue engineering bone material to supercritical fluid cleaning treatment to remove soft tissue in the bone material and obtain an initial bone matrix; a sterilization step, sterilizing the initial bone matrix by supercritical fluid to obtain a bone matrix; and a compounding step, compounding a cytokine into pores of the bone matrix by means of supercritical fluid to obtain the bone scaffold.

Abstract: The present invention relates to a composition for use as an adjunct in orthopaedic surgery, such as in the treatment of i) delayed fracture healing in bone, manifesting as either a delayed or non-union; ii) in a fusion procedure anywhere in the skeletal system, such as cranial, spinal, foot and ankle, or upper limb; and iii) for use as a bone void filler and to enhance bone in-filling in situations of bone loss such as following combat, e.g. blast injuries, or non-combat related trauma such as road-traffic accidents.

Abstract: The present invention relates to adhesive and electroconductive cardiopatches designed to provide mechanical support and restore electromechanical coupling at the site of MI to minimize cardiac remodeling and preserve normal cardiac function.

Abstract: A biocompatible hydrogel has between 0.3% and 30% by weight of dry matter of a copolymer formed at least from acrylamide, chitosan and N,N?-methylenebisacrylamide, as well as a diffusing agent. The diffusing agent is advantageously selected from the group consisting of inert ingredients which have biomechanical properties and active ingredients. A method of manufacturing the hydrogel by copolymerizing, washing, and adding the diffusing agent is provided, as well as a mechanical visco-supplementation system adapted for external or internal use that includes the hydrogel, and an external or internal mechanical visco-supplementation kit including an acrylamide and chitosan copolymer crosslinked with N,N?-methylenebisacrylamide, and a diffusing agent in solid phase or in suspension, the copolymer and the diffusing agent having been previously mixed in the form of a hydrogel during manufacture or being adapted to be mixed extemporaneously to form a hydrogel.

Abstract: A method for making a biomaterial with a target property, the method comprising: obtaining a precursor biomaterial in a precursor biomaterial vessel, and a biomaterial vessel for compacting the precursor biomaterial therein, wherein a relative reduction in a given dimension of the precursor biomaterial in the precursor biomaterial vessel relative to the given dimension in the formed biomaterial in the biomaterial vessel (compaction factor) is based on the target property of the biomaterial and a change in the property of the biomaterial with the compaction factor.

Abstract: Methods and materials for mitigating biological tissue adhesion are described herein. One method for mitigating adhesion to a biological tissue includes administering an effective amount of a self-assembling peptide solution to the biological tissue, wherein the self-assembling peptide is between about 7 amino acids and 32 amino acids in length and the self-assembling peptide solution forms a hydrogel under physiological conditions.

Abstract: In some aspects, the present invention provides surgical procedures that comprise applying compositions into and/or onto tissue, including supporting tissues (e.g., ligaments, connective tissue, muscles, etc.) for pelvic organs, among other tissues. In other aspects, the present disclosure pertains to compositions that are useful for performing such procedures. In still other aspects, the present disclosure pertains to kits that are useful for performing such procedures.

Abstract: A wearable breastmilk collection device includes a storage compartment with a flange and a cup, a breast accepting flange separated from the storage compartment by a one-way valve, a vacuum source attachment, and a reservoir in communication with the vacuum source attachment. A method of expressing and collecting breastmilk from a breast may involve using the wearable breastmilk collection device described above to express breastmilk from the breast, while the device is positioned in the woman's brassiere.

Abstract: A vibratory myofascial decompression apparatus includes a cup and at least one electrically operated vibration element positioned external to the cup. The cup includes a cup body defining an internal cavity and a lip that defines an opening into the internal cavity, with the lip being configured to contact a skin surface of a user. The cup also includes an exhaust port positioned inside the internal cavity configured to permit air to be withdrawn from the internal cavity. The at least one electrically operated vibration element is coupled with the cup to permit vibration to be transmitted through the cup body and the lip to the skin of the user.

Abstract: A blood purification device includes a blood circuit for extracorporeally circulating blood of a patient; a liquid supply line for supplying a supply liquid to a blood purifier provided on the blood circuit or to the blood circuit a peristaltic liquid supply pump provided on the blood circuit or on the liquid supply line; a peristaltic waste liquid pump provided on a waste liquid line through which a waste liquid is discharged from the blood purifier; a water balance amount detection unit for detecting a water balance amount of the supply liquid and the waste liquid; and a water balance amount control unit that corrects one or both of pump speeds of the liquid supply pump and the waste liquid pump so that the water balance amount detected by the water balance amount detection unit matches a target water balance amount.

Abstract: A dialysis machine (e.g., a peritoneal dialysis (PD) machine) can include a safety feature that enables the dialysis machine to automatically identify the connections made by a user in preparation for treatment. A smart connector is disclosed that uses a split RFID device that is operational when a first portion of the connector is mated to a second portion of the connector, and is not operational when the first portion is disconnected from the second portion. In an embodiment, the split RFID device incorporates an RFID chip in the first portion of the connector and an antenna in the second portion of the connector. In an embodiment, the RFID chip can store a tag that encodes information that indicates a formulation or a volume of a dialysis bag connected to the ports of a disposable cassette such that the dialysis machine can automatically discover the configuration of the dialysis setup.

Abstract: A filter apparatus for removing small molecule chemotherapy agents from blood is provided. The filter apparatus comprises a housing with an extraction media comprised of polymer coated carbon cores. Also provided are methods of treating a subject with cancer of an organ or region comprising administering a chemotherapeutic agent to the organ or region, collecting blood laded with chemotherapeutic agent from the isolated organ, filtering the blood laden with chemotherapeutic agent to reduce the chemotherapeutic agent in the blood and returning the blood to the subject.

Abstract: A blood purifier includes a porous molded body; exhibits an excellent blood compatibility wherein platelet adherence is inhibited and exhibits a good cytokine adsorption capacity and a low pressure loss before and after blood treatment; and can be safely used. A blood purifier includes a main vessel and a porous molded body housed in the main vessel. The porous molded body contains a hydrophobic polymer and a hydrophilic polymer. The amount of low-melting-point water per 1 g of dry weight of the porous molded body is 0.12 g to 2.00 g. The contact change ratio for the porous molded body is 0% to 0.2%. The ratio L/D is 1.00 to 2.30 where, for the region taken up by the porous molded body in the main vessel, L is the length in the flow direction and D is the circle-equivalent diameter of the cross section in the direction perpendicular to the flow direction.

Abstract: A blood purification device includes a blood circuit for extracorporeally circulating blood of a patient; a liquid supply circuit for supplying a supply liquid to the blood circuit or to a blood purifier provided on the blood circuit and a waste liquid circuit for discharging the waste liquid from the blood purifier. Each of the blood circuit, the liquid supply circuit and the waste liquid circuit comprises a flexible tube. The blood purification device comprises a tube identification unit that performs a tube identification process for identifying a tube used for the blood circuit, the liquid supply circuit or the waste liquid circuit or determining whether or not there is an abnormality in the tube, based on an amount of liquid sent from a peristaltic pump provided on the blood circuit, the liquid supply circuit or the waste liquid circuit, or pressure fluctuation in the circuit, caused when driving the pump for a predetermined time.

Abstract: A method of placing a cardiac drainage cannula into a patient's heart is provided. The method may comprise the steps of (a) inserting the cannula percutaneously into an internal jugular vein, (b) advancing the cannula through the internal jugular vein and into the right atrium of the heart, and (c) advancing the cannula through the atrial septum into the left atrium of the heart. A method of draining blood from the left atrium or left ventricle of a patient's heart using a cardiac drainage cannula is provided. A cardiac drainage cannula and a mechanical circulatory support system are also provided.